CD4+ T cells have been shown to elicit the most robust bacterial killing in the adaptive response in humans due to their production of the pro-inflammatory cytokine, IFN-γ, which activates macrophages in the adaptive phase to eliminate bacteria (most efficiently) at the later stages of infection (66). The gene discussed is CD4; the disease is infection.